PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 26559558-1 2016 The present retrospective cohort study was conducted to investigate whether serum anti-Mullerian hormone (AMH) levels, determined by either the Immunotech (IOT) or the second generation (Gen II) assay, can predict follicular recruitment in women with polycystic ovary syndrome (PCOS) undergoing ovulation induction with clomiphene citrate (CC). Clomiphene 320-338 anti-Mullerian hormone Homo sapiens 106-109 24419495-2 2014 SUMMARY ANSWER: Anti-Mullerian hormone (AMH) appeared to be an independent predictor of the required dosage of FSH to achieve monofollicular development for ovulation induction in a study sample of clomiphene-resistant PCOS patients. Clomiphene 198-208 anti-Mullerian hormone Homo sapiens 40-43 18028738-6 2007 There was a significant difference in AMH concentration between women with PCOS and the control group (P < 0.05) and also between women with PCOS who responded to clomiphene citrate and those who did not (P < 0.01). Clomiphene 166-184 anti-Mullerian hormone Homo sapiens 38-41 21807466-10 2011 Concerning PCOS, the correlation between AMH and LH can be used in the future for the assessment of the severity of PCOS, of the amelioration of PCOS under OCs treatment, as well as of the efficacy of infertility treatment in clomiphene resistant PCOS women. Clomiphene 226-236 anti-Mullerian hormone Homo sapiens 41-44 23979947-0 2013 The predictive value of circulating anti-Mullerian hormone in women with polycystic ovarian syndrome receiving clomiphene citrate: a prospective observational study. Clomiphene 111-129 anti-Mullerian hormone Homo sapiens 36-58 19640893-6 2009 RESULTS: The pretreatment median (range) plasma AMH concentrations were 6.1 (1.0-21.0) and 5.7 (1.3-9.5) ng/ml in women having LOD and clomiphene citrate treatment, respectively. Clomiphene 135-153 anti-Mullerian hormone Homo sapiens 48-51 19640893-10 2009 For all patients (n = 47, clomiphene citrate or LOD), plasma AMH >or=7.7 ng/ml was associated with a reduced chance of ovulation after treatment (P = 0.004). Clomiphene 26-44 anti-Mullerian hormone Homo sapiens 61-64 18028738-7 2007 A value of 1.2 ng/ml AMH could be used to predict response to clomiphene citrate in obese women with PCOS (sensitivity 71%, specificity 65.7%). Clomiphene 62-80 anti-Mullerian hormone Homo sapiens 21-24 18028738-9 2007 AMH measurement could also be useful in the prediction of ovarian response to clomiphene citrate. Clomiphene 78-96 anti-Mullerian hormone Homo sapiens 0-3 33934267-1 2021 PURPOSE: To assess whether anti-Mullerian hormone (AMH) can predict response to ovulation induction (OI) with clomiphene citrate (CC), letrozole (LET), or follicle-stimulating hormone (FSH) in women with polycystic ovary syndrome (PCOS) undergoing OI/intrauterine inseminations (IUI). Clomiphene 110-128 anti-Mullerian hormone Homo sapiens 27-49 33934267-1 2021 PURPOSE: To assess whether anti-Mullerian hormone (AMH) can predict response to ovulation induction (OI) with clomiphene citrate (CC), letrozole (LET), or follicle-stimulating hormone (FSH) in women with polycystic ovary syndrome (PCOS) undergoing OI/intrauterine inseminations (IUI). Clomiphene 110-128 anti-Mullerian hormone Homo sapiens 51-54 33246461-2 2020 In this study, we aimed to analyze the correlation of the serum AMH level with ovarian responsiveness, embryonic outcomes, and cumulative live birth rates in clomiphene citrate (CC)-based minimal ovarian stimulation cycles. Clomiphene 158-176 anti-Mullerian hormone Homo sapiens 64-67 32528768-2 2020 Anti-Mullerian hormone (AMH) not only reflects the ovarian reserve but also is known to be a predictor of several assisted reproductive techniques, e.g., in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and clomiphene citrate challenge test. Clomiphene 229-247 anti-Mullerian hormone Homo sapiens 24-27 32528768-3 2020 In this study, AMH levels are correlated with the follicular output rate after the clomiphene citrate challenge test. Clomiphene 83-101 anti-Mullerian hormone Homo sapiens 15-18 32528768-4 2020 Objective The objective of this study is to correlate AMH with the follicular output rate (FORT) after the clomiphene citrate challenge test. Clomiphene 107-125 anti-Mullerian hormone Homo sapiens 54-57 32528768-10 2020 Conclusion It is concluded that the most commonly administered drug, clomiphene citrate, may not be the treatment of choice for patients with high levels of AMH and may, in fact, interfere with the chances of achieving pregnancy. Clomiphene 69-87 anti-Mullerian hormone Homo sapiens 157-160 32528768-11 2020 This study can provide guidelines to clinicians for patient counseling, given the results of the clomiphene citrate challenge test on the basis of AMH levels. Clomiphene 97-115 anti-Mullerian hormone Homo sapiens 147-150 30141889-10 2018 In conclusion, the resistance to clomiphene manifested by the patient might be explained by a potential mechanism implicating inhibin B and AMH due to the presence of a GCT. Clomiphene 33-43 anti-Mullerian hormone Homo sapiens 140-143 27228002-1 2017 Aim of the study was to asses and compare serum anti-Mullerian harmone (AMH) levels after laparoscopic ovarian drilling (LOD) and transvaginal hydrolaparoscopy (THL) ovarian drilling in clomifene citrate (CC)-resistant polycystic ovary syndrome (PCOS) patients; secondary outcome was to evaluate postoperative pain to estimate the acceptability of procedures. Clomiphene 186-203 anti-Mullerian hormone Homo sapiens 72-75 28090459-1 2016 OBJECTIVE: This study aimed to determine the threshold of anti-Mullerian hormone (AMH) as predictor of follicular growth failure in polycystic ovary syndrome (PCOS) patients treated with clomiphene citrate (CC). Clomiphene 187-205 anti-Mullerian hormone Homo sapiens 82-85 30044165-0 2019 The role of anti-Mullerian hormone in predicting clomiphene citrate resistance in women with polycystic ovarian syndrome. Clomiphene 49-67 anti-Mullerian hormone Homo sapiens 12-34 30342657-0 2018 The role of anti-Mullerian hormone in predicting the response to clomiphene citrate in unexplained infertility. Clomiphene 65-83 anti-Mullerian hormone Homo sapiens 12-34 30342657-1 2018 OBJECTIVE: To determine the role of anti-Mullerian hormone (AMH) levels in predicting the response to clomiphene citrate (CC) therapy for ovulation induction in women with unexplained infertility. Clomiphene 102-120 anti-Mullerian hormone Homo sapiens 36-58 30342657-1 2018 OBJECTIVE: To determine the role of anti-Mullerian hormone (AMH) levels in predicting the response to clomiphene citrate (CC) therapy for ovulation induction in women with unexplained infertility. Clomiphene 102-120 anti-Mullerian hormone Homo sapiens 60-63